Literature DB >> 32343695

Reasons for patient non-compliance with compression stockings as a treatment for varicose veins in the lower limbs: A qualitative study.

Jian-Mei Gong1, Jian-Shi Du1,2, Dong-Mei Han2, Xin-Yu Wang2, Shao-Long Qi2.   

Abstract

The study aims to explore the comprehensive reasons for patients' non-compliance with graded elastic compression stockings (GECS) as the treatment for lower limb varicose veins. Phenomenological analysis was applied in this qualitative study. The patients diagnosed with lower limb varicose veins and undergoing elective surgery who showed non-compliance with GECS as the treatment were invited to have semi-structured, in-depth, face-to-face interviews. Colaizzi method was employed to analyze the data for emerging themes associated with the reasons for patients' non-compliance. Four main themes and nine subthemes related to the reasons for non-compliance with GECS for lower limb varicose veins were summarized. The main themes that emerged were (1) gaps in the knowledge of GECS therapy as a treatment for lower limb varicose veins, (2) few recommendations from the doctors and nurses, (3) disadvantages of GECS, and (4) sociopsychological factors. These themes provide data for policy and planning to improve patients' compliance with GECS in China. Patients, healthcare professionals, and policy makers should share the responsibility to improve patients' compliance with GECS therapy.

Entities:  

Year:  2020        PMID: 32343695      PMCID: PMC7188228          DOI: 10.1371/journal.pone.0231218

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Lower limb varicose veins is a common condition and in China approximately 8.89% to 16.5% of the population is affected by it [1]. Graded elastic compression stockings (GECS) are the first-line treatment for lower limb varicose veins, since they provide the best overall results for patients [2]. Not only can GECS therapy delay disease progression, but it also improves the patients’ quality of life by maintaining the patients’ mobility. “Chinese experts’ consensus on the diagnosis and treatment of chronic venous diseases (CVD)” suggested that patients with CVD should undergo compression therapy throughout the treatment process [3]. Patients’ compliance is the cornerstone of GECS therapy. In fact, non-compliance with prescribed GECS is an apparent major cause of treatment failure. Unfortunately, patients affected by lower limb varicose veins tend to display low compliance with GECS therapy. Raju reported that 63% of patients did not comply with the prescribed regulations after using GECS for a period of time [4]. According to Ziaja’s study, which included a total of 16,770 patients diagnosed with CVD, 25.6% of whom used GECS as a treatment, 46.6% of the patients were never prescribed GECS therapy [5]. Another study reported that 29.2% of the patients were wearing GECS, but only 10.4% did so on a daily basis [6]. In addition, Inasi found that only 11.5% of the patients who were prescribed compression stockings used them regularly [7]. Poor compliance can exacerbate disease progression caused by varicose veins in the lower extremities, such as secondary edema and ulcers, among others. Kapp found that the participants who did not adhere were nine times more likely to have their wound to recur [8]. A randomized controlled trial found that non-compliant patients with healed venous leg ulcers were at a significantly greater risk of venous leg ulcers recurrence [9]. The medical effectiveness of GECS therapy as a treatment for lower limb varicose veins has been demonstrated using clinical trials. However, the success of GECS treatment largely depends on patients’ compliance. Unfortunately, data on patients’ compliance with GECS therapy are lacking in China. Previous research studies on the reasons why patients display poor compliance with GECS are mostly quantitative: questionnaires with limited options were used to choose and narrow the range of factors and thus yielded limited results. In Rastel’s study, only 10 factors were set for non-adherence to GECS therapy in non-complicated primary varicose veins when patients stopped wearing compression [6], while there were only four reasons for GECS non-compliance which were stated in another study [9]. The reasons for patients’ non-compliance with compression stockings as a treatment for lower limb varicose veins are multidimensional and complicated, and furthermore, investigations into comprehensive factors influencing compliance with GECS are limited, thus further investigations are needed [10]. To that end, the present study used a qualitative research method to comprehensively explore the factors affecting patients’ compliance with GECS for the treatment of lower limb varicose veins.

Materials and methods

Phenomenological analysis was applied in this qualitative study whose aim is to understand the meaning and essence of participants’ experiences in a specific situation. We try to understand the subjective experiences of participants by returning to the situation itself. In the phenomenological approach, the situation itself refers to the subjective feelings, perceptions, and reactions experienced by the participants in a specific life scene [11]. The study followed a descriptive qualitative design using semi-structured, in-depth, face-to-face interviews to explore the reasons for non-compliance with GECS in patients diagnosed with lower limb varicose veins at the China-Japan Union Hospital of Jilin University from September to October, 2019. This method was chosen as it increased the understanding of the many reasons affecting patients’ compliance with GECS therapy and will help to develop qualitative tools and categories of inquiry in the future. Purposive sampling was used to recruit participants who were representative of non-compliance with GECS [12]. The participants were patients who had been affected by lower limb varicose veins above ten years and were once recommended to use GECS to avoid aggravation of the condition. Additionally, they all had a history of low adherence to GECS treatment, which led to their condition worsening and thus having to undergo an elective surgery, as documented by their physicians. The inclusion criteria are listed in Table 1. The sample size was determined according to the saturation principle. Saturation principle should be measured from the perspective of interviewees and researchers. From the perspective of the interviewees, if the interviewees have finished their words or have no relevant content to express, the information has been saturated. From the researcher’s point of view, if the researcher is unable to gather new information and the information obtained is sufficient to analyze objective of his research, then the information is saturated [13]. The participants were to be representative in terms of gender, age, education, and type of medical insurance.
Table 1

Inclusion criteria.

No.Inclusion criteria
1The patients were 18 years old or older.
2The patients had been affected by lower limb varicose veins above ten years.
3The patients had been recommended to wear GECS previously.
4The patients had the ability to wear GECS independently without any assistance.
5The patients had no contraindications to GECS such as peripheral artery disease.
6The patients had no cognitive dysfunction or language disorder.
Concerning compliance with GECS as a treatment for CVD, we developed a preliminary draft of our interview profile, because there were no such studies previously. Additionally, vascular surgery and nursing experts (a chief physician, an associate chief physician, a chief nurse, and a nurse-in-charge) were consulted. After pre-interviewing three participants, we revised the preliminary draft and created the final questions as shown in Table 2.
Table 2

The interview outline.

No.Questions
1How old were you when you found the first varicose veins in your lower limbs?
2Did you wear GECS as prescribed?
3Do you know which compression level of GECS you should wear?
4Did you know the benefits of wearing GECS for your disease?
5Do you know the right way to put on and take off GECS?
6Why did you not wear GECS as prescribed?
The authors were all trained in conducting qualitative research and interviews prior to this study. Participants were assigned a code to ensure anonymity, and the interviews were conducted in a single, and quiet room. In general, the interviews took between 20 and 30 minutes and they were audiotaped. The interviewers were instructed to react neutrally to the participants’ answers and to try to remain sensitive and unbiased. Data collection stopped when recurrent patterns became evident in the participants’ narrations and data saturation was reached [12]. The audiotapes were transcribed into text within 48 hours of the interview, and later, the transcriptions were verified with the participants to ensure the authenticity of the data. Data were collected in hospitals, and they were analyzed based on the phenomenological methodology suggested by Colaizzi [14]. The Colaizzi method was used to analyze the data and to find the themes and subthemes that emerged from the interviews. Colaizzi method has seven steps, including (1) familiarization, (2) identifying significant statements, (3) formulating meanings, (4) clustering themes, (5) developing an exhaustive description, (6) producing the fundamental structure, and (7) seeking verification of the fundamental structure [14,15]. This study was focused on clinical realities, and was consistent with the Consolidated Criteria for Reporting Qualitative Research checklist. All participants provided informed verbal consent using a standard script prior to the interviews. Furthermore, the research project was approved by the Ethics Committees of China-Japan Union Hospital of Jilin University (No.2019082111).

Results

Participant characteristics

Ten patients diagnosed with lower limb varicose veins and undergoing elective surgery were recruited. The mean age of the participants was 56.2 years (ranging from 34 to 69 years) and the length of time they had been affected by lower limbs varicose veins ranged from 3 to 36 years. Five (50.0%) were females who had each given birth. One patient (10.0%) had tertiary or higher education, and three (30.0%) had basic education. In addition, three of the participants (30.0%) had CVD in both legs, and four (40%) had CVD on the left leg only. Six (60%) came from urban settings and had social basic medical insurance, and only one participant, who was from a village, did not have any insurance. Full details of participants’ characteristics are described in Table 3.
Table 3

Participants’ characteristics.

ParticipantAgeGenderEducationOccupationCEAP GradeSite of VaricoseVeinsInsurance type
A34FemalePrimary schoolWorkerC4BothCity
B52FemaleTechnical secondary schoolAccountantC3LeftCity
C56MaleJunior high schoolWorkerC4RightCity
D67FemalePrimary schoolPeasantC4RightRural cooperative
E63MaleJunior high schoolWorkerC3LeftProvince
F55FemaleJunior high schoolTeacherC2BothProvince
G69MalePrimary schoolPeasantC4LeftRural Cooperative
H59MaleIlliteratePeasantC3RightSelf-paying
I64FemaleSenior high schoolSalespersonC3LeftCity
J43MaleCollegeGovernment employeeC2BothProvince

Emerging themes

The qualitative analysis revealed nine subthemes and four main themes, as shown in Table 4. The main themes include: (1) gaps in the knowledge of GECS therapy as a treatment for lower limbs varicose veins, (2) few recommendations from the doctors and nurses, (3) GECS’s disadvantages, and (4) sociopsychological factors. Each of these themes is explained below, including quotations from participants with their identification code.
Table 4

Main themes and subthemes identified.

Main ThemesSubthemes
Gaps in the knowledge of GECS therapy as a treatment for lower limb varicose veins.Varicose veins is not a serious disease.
What is GECS and how to use it?
GECS is useless.
Few recommendations from the doctors and nurses.Non-standardized prescription and management of GECS.
Insufficient health education about lower limbs varicose veins and GECS therapy.
Disadvantages of GECS.Putting on GECS is too difficult.
Wearing GECS is too uncomfortable.
Sociopsychological factors.GECS is so expensive.
GECS is ugly.

Theme 1: Gaps in the knowledge of GECS therapy as a treatment for lower limb varicose veins

The participants selected for this study had both convergent and divergent perceptions regarding GECS therapy for varicose veins, which were reflected in the subthemes “Varicose veins is not a serious disease,” “What is GECS and how to use it?” and “GECS is useless.” Subtheme 1: Varicose veins is not a serious disease. There was a convergent cognition that varicose veins was caused by prolonged standing, which was not seen as a threat to life among the participants, particularly among the subjects whose jobs involved standing for long periods of time as they stated. It was found that condescension for varicose disease reduces compliance with GECS. “I’m a teacher, and I think the lower limbs varicose veins may be caused by my job. I’ve heard that elastic stockings are a means of healthcare, but I don’t have any uncomfortable feelings.” (Patient F) “I have been suffering from the lower limbs varicose veins for more than 20 years. At first, only a few veins protruded from the surface of the leg. The doctor had told me to wear GECS previously, but my legs were not in pain or swollen at that time, and I did not comply with the doctor’s advice to wear GECS.” (Patient D) Subtheme 2: What is GECS and how to use it? Most of the patients did not know the classification of pressure, type, size, and material of GECS. There was confusion about how to put them on and take them off, the length of time they should be worn, the cleaning method, and the replacement time of GECS. “The doctor asked me to wear elastic socks, so I went to the pharmacy and bought a pair. But I don’t know how many types of socks there are and the differences between them. I’m not sure I bought the right ones.” (Patient B) Subtheme 3: GECS is useless. GECS therapy is considered to be the first line treatment for CVD, even though it is a long-term process that requires patients to wear them all their lives. However, some participants thought that GECS had no effect on CVD. Others thought the pressure was not sufficient and the symptoms were not relieved quickly enough. Therefore, the perceived therapeutic effect of GECS affects patients’ compliance. “Are these elastic stockings really useful for the varicose veins? I used to wear a pair of elastic stockings for a while which felt really bad. The effect was not obvious, therefore I stopped wearing it.” (Patient A)

Theme 2: Few recommendations from the doctors and nurses

Subtheme 4: Non-standardized prescription and management of GECS. Most of the interviewed participants said that their doctors did not describe GECS in detail, and the doctors or nurses usually told them about it verbally. Only a few healthcare practitioners were actually encouraging patients to try GECS. “The doctor always told me to wear elastic stockings, but he didn’t give me any prescription, nor did the doctors and nurses patiently told me how to choose or wear the elastic stockings. The elastic stockings that I bought were always at the bottom of the drawer.” (Patient J) Subtheme 5: Insufficient health education about lower limb varicose veins and GECS therapy. Based on our findings, we believe that it should be mandatory for doctors and nurses to educate patients about CVD and GECS. This would help patients understand the treatment better. However, due to heavy clinical work, the doctors and nurses usually had little time for health education. “The doctors and nurses would be so busy all day, I generally asked my children to search for information online, and tried my best not to bring too much trouble to doctors and nurses.” (Patient C)

Theme 3: Disadvantages of GECS

Subtheme 6: Putting on GECS is too difficult. In order to guarantee the effectiveness of compression therapy, GECS is made of special materials in a unique production process that adds higher pressure and length to the thigh which bring difficulties to the patients. With the increased pressure level of GECS, the difficulties would also increase. “I am old and my hands and feet are not flexible. It takes a lot of effort to put on the stockings, so I would not wear them.” (Patient J) Subtheme 7: Wearing GECS is too uncomfortable. When wearing the GECS, patients might suffer from compression side effects, such as burning, sweating, itching, pain, and allergies amongst others. This would make patients uncomfortable and lead to them giving up the GECS. “In winter, I can usually wear GECS as required, but in summer they are too hot to wear them.” (Patient G) “It’s hard to wear stockings on the ankle, so I cut off the portion of the foot myself, and the rest will be enough to hold the calf.” (Patient I)

Theme 4: Sociopsychological factors

Subtheme 8: GECS is so expensive. Due to the special materials used to make graduated compression stockings, the price of GECS is usually high, especially when they are imported ones, and further, urban and rural basic medical insurance does not cover GECS therapy. Therefore, patients with low income, such as farmers, would be unable to afford the expensive treatment. Due to being under great psychological pressure to reduce the financial burden of their families, patients would usually give up on wearing GECS. “A pair of stockings sells for several hundred yuan. It’s too expensive without medical insurance.” (Patient H) Subtheme 9: GECS is ugly. Some interviewees thought that GECS had an unaesthetic appearance, therefore, they were not willing to wear them. In addition, some male patients who had traditional viewpoints believed that GECS were a women-specific attire and refused to wear them. Some patients were afraid that GECS would attract others’ attention, which represented a psychological pressure for them. “Sometimes when I was walking in the park, people would come up to me and ask me: what are your stockings for? Is there something wrong with you? They were getting on my nerves.” (Patient E)

Discussion

This qualitative study explored the comprehensive factors influencing patients’ non-compliance with GECS as a treatment for lower limb varicose veins. The resulting factors are grouped into categories that include: (1) gaps in the knowledge of GECS therapy as a treatment for lower limb varicose veins, (2) few recommendations from doctors and nurses, (3) disadvantages of GECS, and (4) sociopsychological factors. These findings are of fundamental importance to clinicians and nurses who treat patients with varicose veins. Results indicated that most patients lacked knowledge about lower limb varicose veins and GECS therapy, which led to poor compliance. Participants believe that varicose veins are not a serious disease, and they did not realize the danger associated with the condition worsening. Some patients did not wear GECS, because they felt that their symptoms were not serious and that their varicose veins had no impact on their work, housework, or quality of life. Additionally, the majority of participants had no idea of the important role of GECS as a treatment for lower limb varicose veins. Further, since GECS is a long-term treatment and thus did not show immediately improvements, patients complained that GECS did not relieve their symptoms quickly enough. As the results revealed, there is poor awareness of lower limb varicose veins and GECS therapy in the Chinese general population. This follows from the existence of insufficient educational programs about GECS therapy in hospitals. This was consistent with Apenteng’s study that reported that patients were less educated about varicose veins, and that health education about GECS was often perfunctory [16]. Kristina Heyer also reported that there was much lower knowledge and practical skills about compression therapy than expected [17]. One of the most relevant factors for compliance is patients’ health education and motivation [18]. Uhl suggested that practitioners’ recommendations are important for better compliance [19]. Learning from example, the Japanese Society of Phlebology established a qualification system for elastic stocking conductors to promote proper usage of GECS in 2002. GECS experts are currently working in outpatient clinics to increase compliance with GECS by meticulous consultation with patients regarding compression therapy [20]. We should learn from Japan’s experience and establish educational programs to increase patients’ compliance with GECS as soon as possible. This study also revealed that there is a lack of awareness about GECS therapy among the clinicians and nurses, which resulted in limited educational programs. In fact, a study reported that knowledge about GECS among Chinese healthcare professionals was poor [21]. Although “Chinese experts agree on the diagnosis and treatment of chronic venous diseases”, suggesting that patients with CVD should accept compression therapy throughout the whole process [3], there are no specific guidelines about GECS therapy. Moreover, there is not a clear division of responsibilities in the medical system regarding GECS therapy. While it should be mandatory for doctors and nurses to provide education for patients, they have little time for health education due to their heavy clinical work. Thus, medical institutions should take this situation seriously and provide training for clinically applying GECS among healthcare professionals [19]. In addition, we should reinforce to develop more complete guidelines of health education about the use of GECS based on both medical and practical points of view [5]. A series of standardized procedures for the treatment of lower limbs varicose veins with GECS therapy should be contained in the guidelines, including doctor’s prescription, measurement, fitting, follow-up, and so on. Beyond that, educational programs led by nurses responsible for sizing and applying GECS and teaching patients the correct usage of GECS are necessary [22]. Professional and standardized management of GECS can help increase the patients’ trust in the treatment. The more the patients believe in the effectiveness of the treatment, the more they will comply with GECS use. Furthermore, healthcare practitioners should prescribe GECS and take into consideration patients’ individual differences, including diagnosis, pressure level, quantity, and length. Above all, more attention should be paid to compliance, which is vital for a treatment’s success, and in particular, the differences between pressure levels and the length of GECS should be studied [21]. Patients’ compliance with lower level of GECS is likely to be higher than compliance to high levels, which suggests that clinicians should consider prescribing lower levels GECS and assess compliance before increasing compression levels. The GECS have several disadvantages as well. To ensure the effectiveness of compression therapy, GECS are designed to have higher pressure and length [23]. When the level of pressure of GECS increases, the difficulties in wearing them will increase, and result in non-compliance. In fact, a study from Brazil showed that the main reason for non-compliance with GECS was difficulties when putting them on [24]. This could be simply remedied by prescribing donning aids which could increase success rates significantly. Sippel found that the success rate of using donning devices to put on one 40 mmHg GECS was 88%. However, without donning devices, success was 60%. Not only can donning aids improve the treatment’s success rate and patients’ compliance with GECS, but they can also increase the patients’ independence, self-efficacy, and quality of life [25]. Chinese nurses could select appropriate donning aids taking into account the patients’ individual differences and teach them how to use these aids. On the other hand, patients might suffer from GECS side effects such as burning, sweating, itching, pain, and allergies amongst others, which would reduce patients’ comfort and compliance with GECS. Rastel found that 32.6% of patients did not wear their compression stockings mainly because they could not tolerate them well [6]. A summation analysis of complications of GECS raised that skin irritation was a common event [10]. A study on the quality of patients’ view of compression therapy also raised the main side effects were dryness of skin, itching, slipping, or constriction [26]. This finding should persuade doctors to recommend accurate prescriptions of GECS by proper measuring, fitting of GECS and addressing the personal and specific needs of the patient to enhanced concordance. Manufacturers also should share the responsibility to look for alternative materials for production to maximize comfort and aesthetic acceptance [27]. Regarding socioeconomic factors, it was found that exorbitant prices bring economic pressure to the patients: the high cost of GECS is a common reason for discontinuation of compression therapy [5]. In Britain, Germany, and other European countries, GECS are listed as one of the statutory tools covered by medical insurance. Meanwhile, Chinese medical insurance is not responsible for covering GECS therapy. Therefore, it is suggested to include GECS therapy in the scope of basic medical insurance reimbursement. The effectiveness of GECS treatment largely depends on the patients’ compliance. However, compliance is hard to assess, as the literature shows. Allaert developed a validated, short, self-administered questionnaire to evaluate the patients’ adherence to the GECS treatment. Physicians and nurses should use this suitable tool to assess patients’ compliance with GECS in their day-to-day practice [28]. In the future, the methods for measuring compliance should also be unified, and medical staff should pay attention to the evaluation of patients’ compliance. At the same time, nurses should develop new methods to evaluate and improve compliance, especially outside the hospital setting [29,30]. There is limited research about the comprehensive factors influencing compliance with GECS therapy for lower limb varicose veins. This is the first qualitative study that explored patients’ attitudes and reasons for non-compliance with GECS therapy from the patients’ perspective by conducting in-depth, face-to-face interviews in the northeast of China to propose effective and targeted management strategies. There are limitations to our purposive sampling that may bias our findings, such as overrepresentation of surgical patients and those with lower educational levels and low compliance.

Conclusions

Poor adherence to treatment is multi-factorial and it was broadly grouped into categories in this study. Based on our findings, we believe it is necessary to establish guidelines about GECS therapy and the associated education programs in China as soon as possible. The medical insurance system should be updated to include coverage of GECS therapy as well. Doctors and nurses should contribute by raising awareness and providing education regarding GECS therapy. Furthermore, the compression stockings’ manufacturers could look for other materials that might be more comfortable for patients. In general, patients, healthcare professionals, and policy makers should share the responsibility to improve patients’ compliance with GECS therapy. (DOCX) Click here for additional data file. (RAR) Click here for additional data file. 21 Jan 2020 PONE-D-19-34825 Reasons for patients’ non-compliance with compression stockings as a treatment for varicose veins in the lower limbs’: A qualitative study PLOS ONE Dear Dr. Du, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The article is potentially interesting for our journal. Provided the authors are willing to improve the manuscript according to reviewers' suggestions, we will reconsider it again. We would appreciate receiving your revised manuscript by Mar 06 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Prof. Raffaele Serra, M.D., Ph.D Academic Editor PLOS ONE Additional Editor Comments (if provided): The article is potentially interesting. I suggest to fix the manuscript according to reviewers' suggestions and resubmit a new version of your article. Journal Requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please amend your current ethics statement to address the following concerns: Please explain why was written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure. 3. Please amend the manuscript submission data (via Edit Submission) to include author DongMei Han, Xinyu Wang and Shaolong Qi 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: A. Overall evaluation and general comments 1. As I am quite skilled in quantitative experiments and almost a beginner in qualitative research, I am not the right person to judge the level of your qualitative research. Anyway, the number of patients is very small (10) and paradoxically less than the sum of the number of themes(4) and subthemes(9). The more the number of categories, the more (much more) are the number of sets of categories, generally in a combinatorial way. This sets the issue of an adequate experimental design. For instance, even if considering just sex(M/F) and CEAP(1-6) the classes are 12, more than the available patients. 2.The paper is missing any report about the qualitative-quantitative tools used to analyze gathered data. Thus, we leave quantitative research but we do not get any qualitative evaluation to help us in our judgements. 3.The article is prolix in some sections. Why not to shorten the text, avoiding repetitions ? 4.In order to shorten the text into a non-verbose and more clear one, provide just one example of patient interview instead of two. B. Detailed evaluation of specific deficiencies with suggestions for improvements1.67 > We were able to identify four main reasons for patients’ noncompliance., Omit the sentence, as it goes in other sections or it is a repetition. 2.75 > Purposive sampling, An intentional (purposive) sampling is just a selection by previous knowledge. Most people are not used to purposive sampling (opposed to probability sampling)... Add therefore a reference. 3.81 > saturation principle, Add a reference. 4.91-95 Report the final questions in a table and delete them from the text 5.344-345 > GECS are listed as one of the statutory diseases covered by medical insurance, GECS are not a disease but a therapeutic tool, the corresponding disease is chronic venous disease (CVD) 6.349 > However, compliance is hard to assess, as the literature shows., Recently wireless accelerometers were adopted to measure the wearing time of GECS. Look at the open access paper "Evaluation of an accelerometer-based device to monitor compliance on patients wearing medical compression stockings. E Grenier, D Rastel, C Chaigneau. JTAVR 2018;3(1):25-32. " ext-link-type="uri" xlink:type="simple">https://doi.org/10.24019/jtavr.51" C. Minor points e.g. grammar or terminology 1.8, 102, 104 Colaizzi's method and Colaizzi method, Decide how to refer to the method and use always the same way. 2.29 condition,, and, in China, approximately, condition and in China approximately 3.42-43 Another study reported that although 29.2% of the patients were wearing GECS, but only 10.4% did so on a daily basis [6]., You have 2 choices: omit "although" or omit "but". They cannot be present together. 4.48 recur, to recur 5.49 found non-compliant patients, found that non-compliant patients 6.50 healed, delete healed 7.55 quantitative, maybe qualitative ? It is not clear. 8.59 GECS non-compliance were stated, GECS non-compliance which were stated 9.62-64 are limited. Therefore, researchers should further investigate the reasons for non-compliance with GECS in order to increase patients’ adherence to the treatment [10], This sentence is a repetition. Why not to say it in a shorter way, i.e.: "are limited, thus further investigations are needed [10]". 10.67 noncompliance, non-compliance 11.86-87 After conducting a systematic review of the research, Omit these words, they are useless 12.104 Colaizzi's method have, has 13.300 education guidelines, "education, guidelines". Without comma the sentence is not understandable. 14.319-320 This is a repetition of lines 213-214. Erase the first or the second occurrence. 15.375 Refernces, References ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. 13 Mar 2020 Dear Prof. Raffaele Serra, Thank you for your letter and for the reviewers' comments concerning our manuscript. We apologize for my late return of our revised manuscript, because our country suffered from severe epidemic—— novel coronavirus pneumonia which brought us a lot of difficulties, so we hope you could accept our apology and give us another chance. According to the comments and suggestions, we have revised the relevant parts of the manuscript and are resubmitting the manuscript. We also responded point by point to the comments from the editor and the reviewers as shown below, and all changes are marked in red in the revised version of the manuscript. Thank you very much for considering our revised manuscript. We look forward to hearing from you at your earliest convenience. With kindest regards, JianMei Gong, JianShi Du, DongMei Han, Xinyu Wang, and Shaolong Qi Responses to Journal Requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf Response: We guarantee that manuscript meets PLOS ONE's style requirements, including those for file naming. 2. Please amend your current ethics statement to address the following concerns: Please explain why was written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure. Response: The ethics statement of this study has been described in 109-112. All participants provided informed verbal consent using a standard script prior to the interviews. Furthermore, the research project was approved by the Ethics Committees of China-Japan Union Hospital of Jilin University (No.2019082111). 3. Please amend the manuscript submission data (via Edit Submission) to include author DongMei Han, Xinyu Wang and Shaolong Qi Response: We have amended the manuscript submission data (via Edit Submission) to include author DongMei Han, Xinyu Wang and Shaolong Qi. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Response: We have included captions for the Supporting Information files at the end of the manuscript, and update any in-text citations to match accordingly. In addition, we have made some changes to the Table 1, Table 2 and Table 3 as shown in red. Responses to the reviewer # 1 [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Response: Questionnaires with limited options which were used to fill by objects in previous studies so that there was narrow the range of factors. It is a basis of quantitative studies that a qualitative research method could comprehensively explore the factors affecting patients’ compliance with GECS for the treatment of lower limb varicose veins. So it is reasonable for us to choose this qualitative research method. Our study was focused on clinical realities which was consistent with the Consolidated Criteria for Reporting Qualitative Research checklist and the data support the conclusions powerfully. ________________________________________ 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Response: Qualitative research is different from quantitative research where statistical analysis is not appropriate. Phenomenological analysis was applied in this qualitative study whose aim is to understand the meaning and essence of participants' experiences in a specific situation. The patients who had a non-compliance of GECS were interviewed in depth about their experiences regarding factors why they did not wear GECS. We try to understand the subjective experiences of participants by returning to the situation itself by phenomenology. Data were collected in hospitals, and it is appropriate and rigorous that Colaizzi method of phenomenological analysis was applied to analyze the data. ________________________________________ 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Response: Thank you for your encouragement. ________________________________________ 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Response: Thank you for your encouragement. ________________________________________ 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Response: I don't think we need a reply here. Reviewer #1: A. Overall evaluation and general comments 1. As I am quite skilled in quantitative experiments and almost a beginner in qualitative research, I am not the right person to judge the level of your qualitative research. Anyway, the number of patients is very small (10) and paradoxically less than the sum of the number of themes(4) and subthemes(9). The more the number of categories, the more (much more) are the number of sets of categories, generally in a combinatorial way. This sets the issue of an adequate experimental design. For instance, even if considering just sex(M/F) and CEAP(1-6) the classes are 12, more than the available patients. Response: It is unnecessary that the sample size is calculated in advance of the qualitative study. When the interviews were conducted till theoretical saturation was achieved such that no new contents appeared in the interviews and the same type of concepts and themes emerged in the data analysis, the sample is saturated. 2.The paper is missing any report about the qualitative-quantitative tools used to analyze gathered data. Thus, we leave quantitative research but we do not get any qualitative evaluation to help us in our judgements. Response: Thanks for the suggestion. We might have omitted the description of this part in the materials and methods, so we have supplemented some report about the qualitative-quantitative tools in the manuscript. For example, Phenomenological analysis was applied in this qualitative study whose aim is to understand the meaning and essence of participants' experiences in a specific situation. We try to understand the subjective experiences of participants by returning to the situation itself. In the phenomenological approach, the situation itself refers to the subjective feelings, perceptions, and reactions experienced by the participants in a specific life scene [11]. Data were collected in hospitals, and they were analyzed based on the phenomenological methodology suggested by Colaizzi [14]. 3.The article is prolix in some sections. Why not to shorten the text, avoiding repetitions ? Response: Thanks for the suggestion. We have erased the repetition in the text according to your recommendations as shown in the Revised Manuscript with Track Changes. 4.In order to shorten the text into a non-verbose and more clear one, provide just one example of patient interview instead of two. Response: Thanks for the suggestion. We have deleted redundant example of patient interview for keeping one according to your recommendations as shown in the Revised Manuscript with Track Changes. B. Detailed evaluation of specific deficiencies with suggestions for improvements 1.67 > We were able to identify four main reasons for patients’ noncompliance., Omit the sentence, as it goes in other sections or it is a repetition. Response: Thanks for the suggestion. We have omitted the sentence according your recommendation. 2.75 > Purposive sampling, An intentional (purposive) sampling is just a selection by previous knowledge. Most people are not used to purposive sampling (opposed to probability sampling). Add therefore a reference. Response: The purpose of sampling is usually applied in the qualitative research instead of random sampling. According to the purpose of the study, “To explore the comprehensive reasons for patients’ non-compliance with graded elastic compression stockings (GECS) as the treatment for lower limb varicose veins” we could only look for those patients with non-adherence to GECS, rather than those who have good adherence. We have added a reference according your recommendation. 12 van Hoeven LR, Janssen MP, Roes KCB, Koffijberg H. Aiming for a representative sample: Simulating random versus purposive strategies for hospital selection. BMC Med Res Methodol, 2015, 15:90 http://doi.org/10.1186/s12874-015-0089-8 PMID: 26497748 3.81 > saturation principle, Response: Thanks for the suggestion. We have added a reference according your recommendation. 12 Pliuskevicius R. On the Saturation Principle for a Linear Temporal Logic. Computational Logic and Proof Theory, 1993, 713: 289-300. http://doi.org/10.1007/BFb0022577 4.91-95 Report the final questions in a table and delete them from the text Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in the Revised Manuscript with Track Changes. Table 2. The interview outline. (1) How old were you when you found the first varicose veins in your lower limbs? (2) Did you wear GECS as prescribed? (3) Do you know which compression level of GECS you should wear? (4) Did you know the benefits of wearing GECS for your disease? (5) Do you know the right way to put on and take off GECS? (6) Why did you not wear GECS as prescribed? 5.344-345 > GECS are listed as one of the statutory diseases covered by medical insurance, GECS are not a disease but a therapeutic tool, the corresponding disease is chronic venous disease (CVD) Response: Thanks for the suggestion. I'm so sorry that we did not pay enough attention to that. We accept the recommendation and have changed “diseases” into “tools” as shown in the Revised Manuscript with Track Changes. 6.349 > However, compliance is hard to assess, as the literature shows., Recently wireless accelerometers were adopted to measure the wearing time of GECS. Look at the open access paper "Evaluation of an accelerometer-based device to monitor compliance on patients wearing medical compression stockings. E Grenier, D Rastel, C Chaigneau. JTAVR 2018;3(1):25-32. https://doi.org/10.24019/jtavr.51" Response: Thanks for the recommendation. The study reported that integration of the system in an elastic compression stocking enables acquisition, analysis and interpretation of an acceleration signal thus providing objective monitoring of patient compliance as a function of the periods of wear and non-wear. But that study is still in the preliminary stage meanwhile there were 5 cases, so large-scale clinical studies were very limited. At present compliance is still hard to assess and we are also exploring this area. C. Minor points e.g. grammar or terminology 1.8, 102, 104 > Colaizzi's method and Colaizzi method, Decide how to refer to the method and use always the same way. Response: We have decided use “Colaizzi method” after confirmation which was revised uniformly in the manuscript. 2.29 > condition,, and, in China, approximately, condition and in China approximately Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in red. 3.42-43 > Another study reported that although 29.2% of the patients were wearing GECS, but only 10.4% did so on a daily basis [6]., You have 2 choices: omit "although" or omit "but". They cannot be present together. Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in red. 4.48 > recur, to recur Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in red. 5.49 > found non-compliant patients, found that non-compliant patients Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in red. 6.50 > healed, delete healed Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in red. 7.55 > quantitative, maybe qualitative ? It is not clear. Response: We accepted the recommendation. But we confirm that is “quantitative” here. We mean previous studies on the reasons why patients display poor compliance with GECS are mostly quantitative studies by questionaires. 8.59 > GECS non-compliance were stated, GECS non-compliance which were stated Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in red. 9.62-64 > are limited. Therefore, researchers should further investigate the reasons for non-compliance with GECS in order to increase patients’ adherence to the treatment [10], This sentence is a repetition. Why not to say it in a shorter way, i.e.: "are limited, thus further investigations are needed [10]". Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in red. 10.67 > noncompliance, non-compliance Response: Thanks for the suggestion. We accepted the recommendation. But because the sentence where “noncompliance” is used has been deleted, there is no need to modify it. 11.86-87 > After conducting a systematic review of the research, Omit these words, they are useless Response: Thanks for the suggestion. We accepted the recommendation and omit these words. 12.104 > Colaizzi's method have, has Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in the Revised Manuscript with Track Changes. 13.300 > education guidelines, "education, guidelines". Without comma the sentence is not understandable. Response: Thanks for the suggestion. We revised this sentences to “In addition, we should reinforce to develop more complete guidelines of health education about the use of GECS based on both medical and practical points of view [5].” 14.319-320 This is a repetition of lines 213-214. Erase the first or the second occurrence. Response: Thanks for the suggestion. We have erased lines 213-214 and revised it to “which bring difficulties to the patients.” 15.375 > Refernces, References Response: Thanks for the suggestion. We accepted the recommendation and revised the manuscript as shown in red. Submitted filename: Response to Reviewers.docx Click here for additional data file. 19 Mar 2020 Reasons for patient non-compliance with compression stockings as a treatment for varicose veins in the lower limbs’: A qualitative study PONE-D-19-34825R1 Dear Dr. Du, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Prof. Raffaele Serra, M.D., Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): amended manuscript is acceptable Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Fausto Passariello 16 Apr 2020 PONE-D-19-34825R1 Reasons for patient non-compliance with compression stockings as a treatment for varicose veins in the lower limbs’: A qualitative study Dear Dr. Du: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Raffaele Serra Academic Editor PLOS ONE
  25 in total

1.  Information point: Colaizzi's framework for analysing qualitative data.

Authors:  C Webb
Journal:  J Clin Nurs       Date:  1999-09       Impact factor: 3.036

2.  Adherence to and efficacy of different compression methods for treating chronic venous insufficiency in the elderly.

Authors:  Kotaro Suehiro; Noriyasu Morikage; Osamu Yamashita; Takasuke Harada; Koshiro Ueda; Makoto Samura; Yuya Tanaka; Yuriko Takeuchi; Kimikazu Hamano
Journal:  Phlebology       Date:  2016-07-09       Impact factor: 1.740

3.  Short-form 6D assessment in compression module of the American College of Phlebology Patient Reported Outcome Venous Registry.

Authors:  Yung-Wei Chi; Blythe Durbin-Johnson; Marlin Schul
Journal:  Phlebology       Date:  2017-06-22       Impact factor: 1.740

4.  Confronting the most challenging risk factor: non-adherence.

Authors:  Richard Kones; Umme Rumana; Alberto Morales-Salinas
Journal:  Lancet       Date:  2018-12-03       Impact factor: 79.321

5.  Compression therapy - cross-sectional observational survey about knowledge and practical treatment of specialised and non-specialised nurses and therapists.

Authors:  Kristina Heyer; Kerstin Protz; Matthias Augustin
Journal:  Int Wound J       Date:  2017-07-25       Impact factor: 3.315

6.  The clinical effectiveness of two compression stocking treatments on venous leg ulcer recurrence: a randomized controlled trial.

Authors:  Suzanne Kapp; Charne Miller; Lisa Donohue
Journal:  Int J Low Extrem Wounds       Date:  2013-09-16       Impact factor: 2.057

Review 7.  Systematic review of patient preference and adherence to the correct use of graduated compression stockings to prevent deep vein thrombosis in surgical patients.

Authors:  Ros Wade; Fiona Paton; Nerys Woolacott
Journal:  J Adv Nurs       Date:  2016-10-09       Impact factor: 3.187

8.  Randomised controlled trial comparing European standard class 1 to class 2 compression stockings for ulcer recurrence and patient compliance.

Authors:  Mary Clarke-Moloney; Niamh Keane; Veronica O'Connor; Mary Anna Ryan; Helen Meagher; Pierce A Grace; Eamon Kavanagh; Stewart R Walsh; Paul E Burke
Journal:  Int Wound J       Date:  2012-10-19       Impact factor: 3.315

9.  Quality of life and patients' view of compression therapy.

Authors:  S Reich-Schupke; F Murmann; P Altmeyer; M Stücker
Journal:  Int Angiol       Date:  2009-10       Impact factor: 2.789

10.  The use of compression stockings for venous disorders in Brazil.

Authors:  J L Cataldo; J M Pereira de Godoy; N de Barros
Journal:  Phlebology       Date:  2011-07-17       Impact factor: 1.740

View more
  1 in total

Review 1.  Comprehensive overview of the venous disorder known as pelvic congestion syndrome.

Authors:  Kamil Bałabuszek; Michał Toborek; Radosław Pietura
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.